Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LAURUS LABS vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LAURUS LABS    MYLAN
EQUITY SHARE DATA
    LAURUS LABS
Mar-23
MYLAN
Dec-18
LAURUS LABS /
MYLAN
5-Yr Chart
Click to enlarge
High Rs6263,978-   
Low Rs2872,190-   
Sales per share (Unadj.) Rs112.11,830.6-  
Earnings per share (Unadj.) Rs14.849.7-  
Cash flow per share (Unadj.) Rs20.8392.5-  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs74.71,980.4-  
Shares outstanding (eoy) m538.65514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.11.7 241.6%   
Avg P/E ratio x30.962.0 49.7%  
P/CF ratio (eoy) x21.97.9 279.2%  
Price / Book Value ratio x6.11.6 392.2%  
Dividend payout %13.50-   
Avg Mkt Cap Rs m245,8401,586,770 15.5%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m5,5740-   
Avg. sales/employee Rs Th026,910.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.7-  
INCOME DATA
Net Sales Rs m60,406941,863 6.4%  
Other income Rs m600-   
Total revenues Rs m60,466941,863 6.4%   
Gross profit Rs m15,922243,719 6.5%  
Depreciation Rs m3,241176,354 1.8%   
Interest Rs m1,65245,300 3.6%   
Profit before tax Rs m11,08922,065 50.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,123-3,510 -89.0%   
Profit after tax Rs m7,96625,575 31.1%  
Gross profit margin %26.425.9 101.9%  
Effective tax rate %28.2-15.9 -177.0%   
Net profit margin %13.22.7 485.7%  
BALANCE SHEET DATA
Current assets Rs m34,617525,936 6.6%   
Current liabilities Rs m24,323383,465 6.3%   
Net working cap to sales %17.015.1 112.7%  
Current ratio x1.41.4 103.8%  
Inventory Days Days1484 17.3%  
Debtors Days Days1093 10.2%  
Net fixed assets Rs m41,987182,706 23.0%   
Share capital Rs m1,077501 214.8%   
"Free" reserves Rs m39,1770-   
Net worth Rs m40,2551,018,924 4.0%   
Long term debt Rs m7,6141,099,746 0.7%   
Total assets Rs m76,6042,733,150 2.8%  
Interest coverage x7.71.5 518.7%   
Debt to equity ratio x0.21.1 17.5%  
Sales to assets ratio x0.80.3 228.8%   
Return on assets %12.62.6 484.2%  
Return on equity %19.82.5 788.4%  
Return on capital %26.63.2 837.1%  
Exports to sales %00-   
Imports to sales %22.70-   
Net fx Rs m29,7500-   
CASH FLOW
From Operations Rs m9,939195,719 5.1%  
From Investments Rs m-9,961-101,165 9.8%  
From Financial Activity Rs m-266-91,177 0.3%  
Net Cashflow Rs m-2971,621 -18.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare LAURUS LABS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare LAURUS LABS With: HIKAL.  CONCORD BIOTECH  AAYUSH FOOD & HERBS   EMMESSAR CHM  TWILIGHT LITAKA PH.  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.